| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.67 | 0.009 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |